The University of Queensland (UQ) Thoracic Research Centre and The Prince Charles Hospital, Brisbane have been awarded $1 million funding from the Australian Cancer Research Foundation (ACRF) for the establishment of ACRF Centre for Lung Cancer Early Detection.
The new Centre will focus on the discovery and development of innovative methods for early stage detection of lung cancer. Lung cancer remains the biggest cause of cancer deaths in Australia and worldwide and has a very low 5-year survival rate in comparison to many other common cancer types. Early detection can therefore significantly improve health and treatment outcomes for patients with lung cancer.
The ACRF Centre for Lung Cancer Early Detection will concentrate on three major innovative research streams: innovations in diagnostic imaging using Low Dose Computed Tomography (LDCT) screening and computer aided diagnosis (CAD); investigating unique molecular profiles and biomarkers of lung cancer; and advanced innovations in Bronchoscopy techniques.
“We are very honoured to receive the ACRF grant to support research into early detection of lung cancer. It will be a major boost for lung cancer research that has been long underfunded in Australia,” said Professor Kwun Fong, Director of University of Queensland Thoracic Research Centre.
“The Centre will greatly enhance capacity and act as a focal point for engaging consumers and clinicians in lung cancer research, educating clinicians and students, mentoring new and developing researchers and translating research innovations into clinical policy and practice worldwide.”
“The grant will greatly boost lung cancer research capability in Australia”, said Professor Ian Brown, CEO of Australian Cancer Research Foundation.
“One of the projects will investigate unique molecules and biomarkers of lung cancer that are likely to be in the exhaled breath of a person with lung cancer from a very early stage. The earlier a cancer is found, the greater is the potential success of the treatment. This is the kind of research ACRF likes to fund. It’s bold and innovative and has the potential to change the way lung cancer is diagnosed.”
The Centre will be based at The Prince Charles Hospital in Brisbane with major collaborations across key Australian and international sites. Due to the clinical focus of the research, the team will be able to translate findings directly into daily clinical practice.
Cover image: Prof Fong receives the ACRF grant.